Personalized Healthcare Firm NantHealth Files for IPO | GenomeWeb

NEW YORK (GenomeWeb) – Personalized healthcare firm NantHealth today announced that it has filed with the US Securities and Exchange Commission for an initial public offering.

NantHealth did not specify how much it aims to raise in the IPO or how many shares it intends to offer. The Culver City, California-based company intends to float its share on the Nasdaq Global Market under the symbol 'NH.'

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.

Sponsored by

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.